At a molecular level, this tumor type is enriched with mutations in TP53, RB1, and PIK3CA, and is associated with the dysregulation of the epithelial–mesenchymal transition pathway [41,96,97] (Figure 4d). This evidence concerns the gene TP53 and neoplasm.